Search Results for Baran, Yusuf, - Narrowed by: TezSirsiDynix Enterprisehttps://catalog.iyte.edu.tr/client/tr_TR/default_tr/default_tr/qu$003dBaran$00252C$002bYusuf$00252C$0026qf$003dITYPE$002509Materyal$002bT$0025C3$0025BCr$0025C3$0025BC$0025091$00253ATEZ$002509Tez$0026rm$003dTEZ$002bKOLEKSIYONU0$00257C$00257C$00257C1$00257C$00257C$00257C0$00257C$00257C$00257Ctrue$0026te$003dILS$0026ps$003d300?2024-05-27T00:50:08ZThe involvement of ceramide metabolizing genes and their products in docetaxel induced apoptosis in human prostate cancer cellsent://SD_ILS/0/SD_ILS:481072024-05-27T00:50:08Z2024-05-27T00:50:08Zby Başsoy, Esen Yonca.<br/><a href="http://hdl.handle.net/11147/3699">Access to Electronic Version.</a><br/>Format: El Yazması<br/>The roles of ceramide metabolizing gennes on resveratrol induced apoptosis in human hl60 acute myeloid leukemia cellsent://SD_ILS/0/SD_ILS:1100392024-05-27T00:50:08Z2024-05-27T00:50:08Zby Çakır, Zeynep.<br/><a href="http://hdl.handle.net/11147/3062">Access to Electronic Version.</a><br/>Format: El Yazması<br/>Synergistic apoptotic effects of bortezomib and methylstat inhibitor on different multiple myeloma cell linesent://SD_ILS/0/SD_ILS:4828792024-05-27T00:50:08Z2024-05-27T00:50:08Zby Kacı, Fatma Necmiye, author.<br/><a href="http://hdl.handle.net/11147/4309">Access to Electronic Versiyon</a><br/>Format: El Yazması<br/>Determination of therapeutic potential of luteolin for acute lymphoblastic leukemia cellsent://SD_ILS/0/SD_ILS:21409452024-05-27T00:50:08Z2024-05-27T00:50:08Zby Gürler, Sevim Beyza, author.<br/><a href="https://hdl.handle.net/11147/10913">Access to Electronic Versiyon.</a><br/>Format: El Yazması<br/>Deciphering 5-fluorouracil mediated molecular mechanisms required for cell deathent://SD_ILS/0/SD_ILS:1407192024-05-27T00:50:08Z2024-05-27T00:50:08Zby Can, Geylani.<br/><a href="http://hdl.handle.net/11147/3166">Acces s to Electronic Version.</a><br/>Format: El Yazması<br/>Increasing chemosensitivity of chronic myeloid leukemia cells to dasatinib by targeting bioactive sphingolipidsent://SD_ILS/0/SD_ILS:1075272024-05-27T00:50:08Z2024-05-27T00:50:08Zby Gencer, Emel Başak.<br/><a href="http://hdl.handle.net/11147/3053">Access to Electronic Version.</a><br/>Format: El Yazması<br/>Examination of therapeutic potential of luteolin on acute lymphoblastic leukemia cells and changes in macromoleculesent://SD_ILS/0/SD_ILS:23425612024-05-27T00:50:08Z2024-05-27T00:50:08Zby Çetinkaya, Melisa, author.<br/><a href="https://hdl.handle.net/11147/13731">Access to Electronic Versiyon.</a><br/>Format: El Yazması<br/>Therapeutic potentials of fisetin, hesperetin and vitexin on chronic myeloid leukemia and acute myeloid leukemia cellsent://SD_ILS/0/SD_ILS:4789552024-05-27T00:50:08Z2024-05-27T00:50:08Zby Adan Gökbulut, Aysun, author.<br/><a href="http://hdl.handle.net/11147/4275">Access to Electronic Versiyon.</a><br/>Format: El Yazması<br/>The mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cellsent://SD_ILS/0/SD_ILS:413882024-05-27T00:50:08Z2024-05-27T00:50:08Zby Camgöz, Aylin.<br/><a href="http://hdl.handle.net/11147/3638">Access to Electronic Version.</a><br/>Format: El Yazması<br/>Determination of therapeutic effects of multifunctional antibody and peptide micelle-based nanocarriers on breast cancer cellsent://SD_ILS/0/SD_ILS:22048762024-05-27T00:50:08Z2024-05-27T00:50:08Zby Abdulhadi, Nusaibah, author.<br/><a href="https://hdl.handle.net/11147/11128">Access to Electronic Versiyon.</a><br/>Format: El Yazması<br/>Sensitization of philadelphia positive acute lymphoblastic leukemia cells resistant to imatinib by targeting sphingolipid metabolisment://SD_ILS/0/SD_ILS:21409602024-05-27T00:50:08Z2024-05-27T00:50:08Zby Kiraz, Yağmur, author.<br/><a href="https://hdl.handle.net/11147/10912">Access to Electronic Versiyon.</a><br/>Format: El Yazması<br/>Determination of therapeutic potential of apigenin on acute lymphoblastic leukemia cellsent://SD_ILS/0/SD_ILS:21406282024-05-27T00:50:08Z2024-05-27T00:50:08Zby Uzuner, Erez, author.<br/><a href="https://hdl.handle.net/11147/10917">Access to Electronic Versiyon.</a><br/>Format: El Yazması<br/>Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cellsent://SD_ILS/0/SD_ILS:21339032024-05-27T00:50:08Z2024-05-27T00:50:08Zby Ulu, Gizem Tuğçe, author.<br/><a href="https://hdl.handle.net/11147/7418">Access to Electronic Versiyon.</a><br/>Format: El Yazması<br/>Expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant chronic myeloid leukemia patients and their impact on the clinical progressent://SD_ILS/0/SD_ILS:4790272024-05-27T00:50:08Z2024-05-27T00:50:08Zby Kartal Yandım, Melis, author.<br/><a href="http://hdl.handle.net/11147/4285">Access to Electronic Versiyon.</a><br/>Format: El Yazması<br/>Activated signaling pathways and apoptotic mechanisms in resveratrol applied chronic myeloid leukemia cells and the involvement of ceramide metabolizing genes on these mechanismsent://SD_ILS/0/SD_ILS:286602024-05-27T00:50:08Z2024-05-27T00:50:08Zby Kartal, Melis.<br/><a href="http://hdl.handle.net/11147/3515">Access to Electronic Version.</a><br/>Format: El Yazması<br/>